Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Ritesh Patil"'
Publikováno v:
International Journal for Research in Applied Science and Engineering Technology. 10:1096-1098
College Website is that the Growing significance of internet sites for various organizations is well known. Today, a well-planned digital strategy plays a significant role in an institution’s marketing strategies — especially considering younger
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4660821ce4ef8a8aaefd4d5ca17ea90
https://doi.org/10.22214/ijraset.2022.41450
https://doi.org/10.22214/ijraset.2022.41450
Publikováno v:
International Journal of Innovations in Engineering and Science. 6:01-07
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec06ec81baadb96250a0385c985fd2d0
https://doi.org/10.46335/ijies.2021.6.4.1
https://doi.org/10.46335/ijies.2021.6.4.1
Autor:
John F. Gibbs, Ritesh Patil, Myron S. Czuczman, Cory Mavis, Juan J Gu, George Deeb, Francisco J. Hernandez-Ilizaliturri, Natalie M Czuczman, Joseph J. Skitzki
Publikováno v:
Anti-Cancer Drugs. 24:1030-1038
To further develop therapeutic strategies targeting the proteasome system, we studied the antitumor activity and mechanisms of action of MLN2238, a reversible proteasome inhibitor, in preclinical lymphoma models. Experiments were conducted in rituxim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8ffd53a0de6883ef1d89bd2ac7b8066
https://doi.org/10.1097/cad.0000000000000008
https://doi.org/10.1097/cad.0000000000000008
Autor:
Alan K. Sears, EA Mittendorf, Guy T. Clifton, Sathibalan Ponniah, Diane F. Hale, JP Holmes, Timothy J. Vreeland, George E. Peoples, Ritesh Patil
Publikováno v:
Cancer Research. 72:P5-16
Background: We have completed phase I/II clinical trials vaccinating breast cancer patients (pts) with E75, a HLA-A2/A3-restricted HER2/neu (HER2) peptide vaccine. The vaccine was administered in the adjuvant setting to prevent recurrences in high ri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::857d586ea368758b81b7b33445362622
https://doi.org/10.1158/0008-5472.sabcs12-p5-16-02
https://doi.org/10.1158/0008-5472.sabcs12-p5-16-02
Autor:
Kevin S. Clive, Sathibalan Ponniah, George E. Peoples, Ritesh Patil, Timothy J. Vreeland, Alan K. Sears, EA Mittendorf, Guy T. Clifton, Diane F. Hale, JP Holmes
Publikováno v:
Cancer Research. 71:P1-13
Background: We are conducting phase I/II clinical trials vaccinating breast cancer patients with E75, an HLA-A2/A3 restricted HER2/neu (HER2) peptide mixed with GM-CSF. The vaccine has been studied in the adjuvant setting to prevent recurrences in cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2aaa54ad0c6e3d2ac67e227abbf7ad5c
https://doi.org/10.1158/0008-5472.sabcs11-p1-13-02
https://doi.org/10.1158/0008-5472.sabcs11-p1-13-02
Autor:
Timothy J. Vreeland, Kevin S. Clive, Ge. Peoples, Sathibalan Ponniah, JP Holmes, Ritesh Patil, Guy T. Clifton, Alan K. Sears, EA Mittendorf
Publikováno v:
Cancer Research. 70:P2-20
Background: We are conducting clinical trials of the HER2/neu E75-peptide+GM-CSF vaccine in clinically disease-free breast cancer patients at high risk for recurrence. Our Phase I/II trials have shown that the vaccine is safe and effective in stimula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2464ff8c3baf3c61befe53e4d3724376
https://doi.org/10.1158/0008-5472.sabcs10-p2-20-01
https://doi.org/10.1158/0008-5472.sabcs10-p2-20-01
Autor:
Sathibalan Ponniah, Kevin S. Clive, Alexander Stojadinovic, Jeremy D. Gates, Ritesh Patil, George E. Peoples, Elizabeth A. Mittendorf, Linda C. Benavides, Jarrod P. Holmes, Alan K. Sears, Guy T. Clifton
The authors conducted exploratory phase 1-2 clinical trials vaccinating breast cancer patients with E75, a human leukocyte antigen (HLA) A2/A3-restricted HER-2/neu (HER2) peptide, and granulocyte-macrophage colony-stimulating factor. The vaccine is g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59f392478ecf91f6e5a3ee8a071d8075
https://europepmc.org/articles/PMC3428069/
https://europepmc.org/articles/PMC3428069/
Autor:
Linda C. Benavides, Elizabeth A. Mittendorf, Jarrod P. Holmes, Jeremy D. Gates, Alexander Stojadinovic, George E. Peoples, Ritesh Patil, Sathibalan Ponniah, Guy T. Clifton
Publikováno v:
Cancer. 117(3)
BACKGROUND: The authors are conducting clinical trials of the HER-2/neu E75-peptide vaccine in clinically disease-free breast cancer (BC) patients. Their phase 1-2 trials revealed that the E75 + granulocyte-macrophage colony-stimulating factor (GM-CS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7368279e043fb9db5d6f211cec4b300a
https://pubmed.ncbi.nlm.nih.gov/20845479
https://pubmed.ncbi.nlm.nih.gov/20845479
Publikováno v:
Journal of general internal medicine. 26(10)
Coagulase negative staphylococci are skin commensals and are generally disregarded as contaminants in clinical specimens. Repeated isolation of coagulase negative staphylococci in blood cultures should warrant a species identification to recognize un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::444847dde74d4700e30a6609e91fd74f
https://pubmed.ncbi.nlm.nih.gov/21538169
https://pubmed.ncbi.nlm.nih.gov/21538169
Autor:
Mark G. Carmichael, Jeremy D. Gates, Matthew T. Hueman, George E. Peoples, Asna Amin, Jarrod P. Holmes, Ritesh Patil, Guy T. Clifton, Sathibalan Ponniah, Linda H. Benavides
Publikováno v:
Journal of the American College of Surgeons. 210(2)
Background We have treated disease-free breast cancer patients with an HER2/ neu -derived peptide, E75, as an adjuvant vaccine. E75 was originally described as HLA-A2−restricted and has been previously tested in this population. Based on computer m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c154c48650843f79acd1a475c0c8864
https://pubmed.ncbi.nlm.nih.gov/20113933
https://pubmed.ncbi.nlm.nih.gov/20113933